Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

NCT05259696 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Oncology
Melanoma
Ovarian Cancer
NSCLC
Non Small Cell Lung Cancer
Colorectal Cancer
Pancreatic Cancer
Cancer
CRC
Colon Cancer
Breast Cancer
Gastric Cancer
EGJ
Esophagogastric Junction Cancer
Head and Neck Cancer
Urothelial Cancer
Bladder Cancer

Interventions

BIOLOGICAL: E-602
BIOLOGICAL: Cemiplimab

Sponsor

Palleon Pharmaceuticals, Inc.